ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
8 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
4 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
Charts
|
MSB |
Re:
MSB charts only hating each other
|
|
yelrom
|
3 |
1.0K |
4 |
25/05/21 |
25/05/21 |
Charts
|
3
|
1.0K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
34 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
422
|
145K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast - all set to boom
|
|
yelrom
|
243 |
90K |
6 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
243
|
90K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
3 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
8 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
13 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Phase 3 Trial Results Presented at Investor Conference
|
|
yelrom
|
18 |
10K |
5 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
18
|
10K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
24 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
422
|
145K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
15 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
422
|
145K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
16 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
422
|
145K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
18 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
422
|
145K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
65 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
422
|
145K
|
65
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
7 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
905
|
286K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
15 |
16/05/21 |
16/05/21 |
ASX - By Stock
|
905
|
286K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
7 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
982
|
285K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
18 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
9.8K |
2.9M |
26 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
9.8K
|
2.9M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
20 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
982
|
285K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
5 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
982
|
285K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
28 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
3 |
08/05/21 |
08/05/21 |
ASX - By Stock
|
905
|
286K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
7 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
905
|
286K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
yelrom
|
1.6K |
464K |
22 |
07/05/21 |
07/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Is there evidence that journalists and others have been colluding to manipulate the SP down?
|
|
yelrom
|
37 |
11K |
22 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
37
|
11K
|
22
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
34 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
34
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
6 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
22 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
26 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
982
|
285K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
8 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
982
|
285K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
yelrom
|
1.6K |
464K |
14 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
yelrom
|
1.6K |
464K |
22 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
regulated capitalism with a safety net
|
|
yelrom
|
52 |
10K |
3 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
52
|
10K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
regulated capitalism with a safety net
|
|
yelrom
|
52 |
10K |
25 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
52
|
10K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
yelrom
|
1.6K |
464K |
13 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
1.6K
|
464K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
8 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
21 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
422
|
145K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.7M |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
6 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
982
|
285K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
10 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
982
|
285K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
yelrom
|
1.6K |
464K |
40 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
1.6K
|
464K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
yelrom
|
982 |
285K |
45 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
982
|
285K
|
45
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
yelrom
|
533 |
191K |
12 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
533
|
191K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
How many red flags do you need?
|
|
yelrom
|
36 |
12K |
38 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
36
|
12K
|
38
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
10 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
15 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
422
|
145K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
yelrom
|
422 |
145K |
0 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
422
|
145K
|
0
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
yelrom
|
533 |
191K |
6 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
533
|
191K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
25 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
25
|
|